fatima zohra ALAOUI

Mrs. fatima zohra ALAOUI


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2016 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
TDTouria Derkaoui
Touria Derkaoui
JBJoaira Bakkach
Joaira Bakkach
MMMohamed Mansouri
Mohamed Mansouri
ALAli Loudiyi
Ali Loudiyi
MFMohamed Fihri
Mohamed Fihri
MMMohcine Bennani Mechita
Mohcine Bennani Mechita
Triple Negative Breast Cancer (TNBC) is defined by a lack of estrogen and progesterone receptor gene expression and by the absence of overexpression on HER2. It is associated to a poor prognosis. We propose to analyze the clinicopathologic and prognostic characteristics of this breast cancer subtype in a Mediterranean population originated or resident in the North of Morocco. We conducted a retrospective study of 279 patients diagnosed with breast cancer between January 2010 and January 2015. Clinicopathologic and prognostic features have been analyzed. Disease-Free Survival (DFS) and Overall Survival (OS) have been estimated. Of all cases, forty-nine (17.6 %) were identified as having triple negative breast cancer with a median age of 46 years. The average tumor size was 3.6 cm. The majority of patients have had invasive ductal carcinoma (91.8 %) and 40.4 % of them were grade III SBR. Nodal metastasis was detected in 38.9 % of the patients and vascular invasion was found in 36.6 % of them. About half of the patients had an early disease (53.1 %) and 46.9 % were diagnosed at an advanced stage. Patients with operable tumors (61.2 %) underwent primary surgery and adjuvant chemotherapy. Patients with no operable tumors (26.5 %) received neoadjuvant chemotherapy followed by surgery, and patients with metastatic disease (12.2 %) were treated by palliative chemotherapy. DFS and OS at 5 years were respectively 83.7 and 71.4 %. Among 49, twelve had recurrences, found either when diagnosing them or after a follow-up. Local relapse was 6.1 %. Lung and liver metastases accounted consecutively for 8.2 and 10.2 %. Bone metastases were found in 4.1 % and brain metastases in 2.1 % of the cases. Our results are in accordance with literature data, particularly what concerning young age and poor prognosis among TNBC phenotype. Therefore, the identification of BRCA mutations in our population seems to be essential in order to better adapt management options for this aggressive form of breast cancer.

13 March 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ALAchraf Laghmich
Achraf Laghmich
FAfatima zohra ALAOUI
fatima zohra ALAOUI
ABAmina Barakat
Amina Barakat
NNNaima Ghailani Nourouti
Naima Ghailani Nourouti
MKMohamed Khattab
Mohamed Khattab
MMMohcine Bennani Mechita
Mohcine Bennani Mechita
Unlike the other hemoglobinopathies, few researches have been published concerningα-thalassemia in Morocco. The epidemiological features and the mutation spectrum of this disease are still unknown. This regional newborn screening is the first to studyα-thalassemia in the north of Morocco. During the period from January 2015 to December 2016, 1658 newborns umbilical blood samples were investigated. Suspected newborns were screened forα-globin defects using Gap-PCR and Multiplex Ligation-dependent Probe Amplification technique. The prevalence ofα-thalassemia, its mutation spectrum, and its allelic frequencies were described for the first time in Morocco. Six differentα-globin genetic disorders were detected in 16 neonates. This screening valued the prevalence ofα-thalassemia in the studied population at 0.96% and showed the wide mutation spectrum and the heterogeneous geographical distribution of the disease. A high rate of carriers was observed in Laouamra, a rural commune in Larache province. Heterogeneity ofα-globin alleles in Morocco explains the high variability ofα-thalassemia severity. This diversity reflects the anthropological history of the country. These results would contribute to the prevention of thalassemia in Morocco directing the design of a nationwide screening strategy and awareness campaign.

26 September 2019 in BioMed Research International
Verified
Journal Article
Open access
ALAchraf Laghmich
Achraf Laghmich
FAfatima zohra ALAOUI
fatima zohra ALAOUI
ZZZeineb ZIAN
Zeineb ZIAN
ABAmina Barakat
Amina Barakat
NNNaima Ghailani Nourouti
Naima Ghailani Nourouti
MMMohcine Bennani Mechita
Mohcine Bennani Mechita
Consanguinity is a social behavior characterized by the arrangement of marriages between relatives. It coincides generally with the geographic distribution of recessive genetic diseases as it increases the likelihood of homozygosis and, consequently, the incidence of their pathologies in the population. In this pilot study, we assess the effect of inbreeding on the burden of hemoglobinopathies in Northern Morocco. From January 2016 to December 2018, 197 children born in the studied region to three ancestral generations and diagnosed with hemoglobinopathies were subject to investigation. The rate of consanguinity in the parents’ generation of children with hemoglobinopathies was 50.25%, with first cousin marriages accounting for 68.69% of consanguineous unions (FI = 0.02). The corresponding rates in the general population, based on a sample of N = 900, were 29.67% and 82.02%, respectively. The marriages between first cousins are the most common among the other types of consanguineous unions. Our study propounds that consanguinity substantially contributes to the hemoglobinopathy burden in the studied region and has changed little over time. Refraining from consanguineous marriages and detecting couples at risk could contribute to the reduction of the incidence of genetic diseases in our country.

3 May 2020 in Hemoglobin
Verified
Journal Article
Closed access
FAfatima zohra ALAOUI
fatima zohra ALAOUI
ALAchraf Laghmich
Achraf Laghmich
NGNaima Ghailani-Nourouti
Naima Ghailani-Nourouti
ABAmina Barakat
Amina Barakat
MMMohcine Bennani Mechita
Mohcine Bennani Mechita
Sickle cell disease is one of the most common severe monogenic disorders in the world. The –158 XmnI polymorphism (C>T) of the Gγ-globin gene promoter is known to be associated with increased expression of the Gγ-globin gene, thus, higher production of Hb F and lesser clinical severity. This study aims to determine the frequency of the XmnI polymorphism and its association with Hb F levels as a modulating factor of sickle cell disease severity in north Moroccan patients. Three hundred and eight subjects carrying the sickle cell mutation and 160 healthy individuals were recruited at the regional hospital of Larache, Morocco. The complete blood count and the Hb F levels were analyzed. The XmnI polymorphism was determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique and statistical analysis were done using the Statistical Package for Social Sciences software version 20. Our results estimated the allelic frequency of the XmnI polymorphism in our population at 15.8%. Out of 468 samples, 7.6% were homozygous [+/+] and 16.4% were heterozygous [+/−] for the XmnI polymorphism. This polymorphism was revealed at 20.6% in SS patients, 24.2% in AS carriers, 28.6% in Hb S (HBB: c.20A>T)/β-thalassemia (β-thal) patients and 22.5% in AA subjects. The north Moroccan sickle cell disease patients have shown a low frequency of the XmnI polymorphism. This was later found to be associated with high Hb F levels and mild clinical severity.

3 September 2020 in Research Square
Verified
Preprint
Open access
PDF file
FAfatima zohra ALAOUI
fatima zohra ALAOUI
ALAchraf Laghmich
Achraf Laghmich
NNNaima Ghailani Nourouti
Naima Ghailani Nourouti
ABAmina Barakat
Amina Barakat
MMMohcine Bennani Mechita
Mohcine Bennani Mechita
Background: Hemoglobinopathies are the most frequent widely spread genetic disorders. In Morocco, epidemiological and clinical data are scarce. The present study aims to determine the spectrum and geographic distribution of hemoglobinopathies in Larache province, North of Morocco.Methods: A retrospective cross-sectional study was conducted from January 2015 to December 2018 at the provincial hospital of Larache city. All patients’ records having a hemoglobinopathy were analyzed. Background data (age, gender, and origin) of each case were analyzed. Results: Our study showed an overall frequency of hemoglobinopathies of 3.6%. Sickle cell trait was registered to be the most common disorder in our studied population (42.3%), followed by β-thalassemia Trait (20.2%), sickle cell disease (19.8%), major β-thalassemia (9.8%) and sickle/β-thalassemia (8%). The average age of subjects with hemoglobin disorders was 17.5 years. The majority of the patients (66.5%) were less than 20 years old. A disparity in the diseases geographic distribution was observed, 74.6% of patients came from rural areas. Conclusions: The present study is the first of its kind offering comprehensive data on hemoglobinopathies pattern in Northern Morocco. Our work may lay the foundation for screening programs for better prevention and coverage.

1 January 2026 in The North African Journal of Food and Nutrition Research
Verified
Journal Article
Open access
PDF file
SMSiham El Moussaoui
Siham El Moussaoui
TDTouria Derkaoui
Touria Derkaoui
FAfatima zohra ALAOUI
fatima zohra ALAOUI
EBEl Arbi Bouaiti
El Arbi Bouaiti
ALAbdelilah Laraqui
Abdelilah Laraqui
MMMohcine Bennani Mechita
Mohcine Bennani Mechita
Background: Trimethylamine-N-oxide (TMAO) is a hepatic metabolic co-product derived from dietary precursors via gut microbiota-mediated biotransformation. Although recently implicated as a critical molecular bridge relating dietary patterns to diverse systemic pathologies, the precise impact of TMAO on colorectal cancer (CRC) pathogenesis, etiology, and progression remains largely unresolved. Aims: This study aimed to investigate the association between circulating TMAO levels and various clinical, dietary, and behavioral risk factors associated with colorectal carcinogenesis within a cohort of Moroccan patients. Patients and Methods: In this cross-sectional study, patients were consecutively recruited over a 12-month period from the Ibn Rochd University Hospital in Casablanca and the Mohammed V Military Hospital in Rabat. Face-to-face interviews were conducted to evaluate dietary intake, nutritional patterns, lifestyle behaviors, and clinical phenotypes. Whole blood samples were collected, and serum TMAO concentrations were quantified through liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Results: Globally, no significant correlation was observed between circulating TMAO concentrations and the overall CRC risk. However, highly significant specific associations were identified between elevated TMAO levels and tumor localization at the Hepatic flexure. Furthermore, significant correlations emerged between TMAO concentrations and distinct CRC symptomatologies, including rectal bleeding volume, chronic diarrhea, narrowed stool caliber, tenesmus (the sensation of incomplete rectal emptying), and fatigue. Regarding dietary habits, high-protein dietary adherence was positively correlated with elevated circulating TMAO concentrations, whereas a high consumption of plant-based whole foods was inversely associated with serum TMAO concentrations. Additionally, socioeconomic status and alcohol intake were found to modulate serum TMAO profiles. Conclusions: While these findings demonstrate no direct association between circulating TMAO levels and overall CRC risk, they underscore the clinical necessity of considering dietary patterns when interpreting TMAO biomarkers in oncological cohorts. These outcomes highlight the critical imperative to develop tailored nutritional guidelines for CRC patients and to implement structured nutritional education programs within oncology centers to promote a healthy and balanced diet as an essential component of comprehensive CRC management. Keywords: Colorectal Cancer; Trimethylamine-N-oxide (TMAO); Diet; Morocco.